Sustained Complete Remission in Sézary Syndrome using Extracorporeal Photopheresis: A Multicentric Case Series

Olsen EA, Whittaker S, Willemze R, Pinter-Brown L, Foss F, Geskin L, et al. Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC. Blood 2022; 140: 419-437.

https://doi.org/10.1182/blood.2021012057 DOI: https://doi.org/10.1182/blood.2021012057

de Masson A, Beylot-Barry M, Ram-Wolff C, Mear JB, Dalle S, d'Incan M, et al. Allogeneic transplantation in advanced cutaneous T-cell lymphomas (CUTALLO): a propensity score matched controlled prospective study. Lancet 2023; 401: 1941-1950. DOI: https://doi.org/10.1016/j.ejca.2023.113038

https://doi.org/10.1016/S0140-6736(23)00329-X DOI: https://doi.org/10.1016/S0140-6736(23)00329-X

Knobler R, Arenberger P, Arun A, Assaf C, Bagot M, Berlin G, et al. European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1. J Eur Acad Dermatol Venereol 2020; 34: 2693-2716.

https://doi.org/10.1111/jdv.16890 DOI: https://doi.org/10.1111/jdv.16890

Willemze R, Hodak E, Zinzani PL, Specht L, Ladetto M. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018; 29: iv30-iv40.

https://doi.org/10.1093/annonc/mdy133 DOI: https://doi.org/10.1093/annonc/mdy133

Scarisbrick JJ, Hodak E, Bagot M, Stranzenbach R, Stadler R, Ortiz-Romero PL, et al. Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force. Eur J Cancer 2018; 93: 47-56.

https://doi.org/10.1016/j.ejca.2018.01.076 DOI: https://doi.org/10.1016/j.ejca.2018.01.076

Booken N, Weiss C, Utikal J, Felcht M, Goerdt S, Klemke CD. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome. J Dtsch Dermatol Ges 2010; 8: 428-438.

https://doi.org/10.1111/j.1610-0387.2010.07319.x DOI: https://doi.org/10.1111/j.1610-0387.2010.07319.x

Bozonnat A, Beylot-Barry M, Dereure O, D'Incan M, Quereux G, Guenova E, et al. Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study. EClinicalMedicine 2024; 73: 102679. DOI: https://doi.org/10.1016/j.eclinm.2024.102895

https://doi.org/10.1016/j.eclinm.2024.102679 DOI: https://doi.org/10.1016/j.eclinm.2024.102679

Campbell BA, Dobos G, Haider Z, Prince HM, Bagot M, Evison F, et al. International study of treatment efficacy in SS shows superiority of combination therapy and heterogeneity of treatment strategies. Blood Adv 2023; 7: 6639-6647.

https://doi.org/10.1182/bloodadvances.2023011041 DOI: https://doi.org/10.1182/bloodadvances.2023011041